INHIBITORS OF ADRENORECEPTOR ADRAC2

The present application relates to novel substituted heterocyclic carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases and to their use for producing medicaments for the treatment and/or prevention of diseases, in par...

Full description

Saved in:
Bibliographic Details
Main Authors DIETZ, Lisa, LINDNER, Niels, BECKER-PELSTER, Eva Maria, MÜLLER, Thomas, SCHMECK, Carsten, MEIBOM, Daniel, BUCHGRABER, Philipp, PLATZK, Magdalena, HAHN, Michael, DELBECK, Martina
Format Patent
LanguageEnglish
Published 13.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present application relates to novel substituted heterocyclic carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases and to their use for producing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of breathing difficulties including sleep-induced breathing difficulties such as central and obstructive sleep apnoea, snoring (primary and obstructive snoring), dysphagia, peripheral and cardiac vascular disorders including diabetic microangiopathies and disorders of the peripheral and central nervous system including neurodegenerative and neuroinflammatory disorders.
AbstractList The present application relates to novel substituted heterocyclic carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases and to their use for producing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of breathing difficulties including sleep-induced breathing difficulties such as central and obstructive sleep apnoea, snoring (primary and obstructive snoring), dysphagia, peripheral and cardiac vascular disorders including diabetic microangiopathies and disorders of the peripheral and central nervous system including neurodegenerative and neuroinflammatory disorders.
Author DELBECK, Martina
MEIBOM, Daniel
HAHN, Michael
LINDNER, Niels
BECKER-PELSTER, Eva Maria
DIETZ, Lisa
PLATZK, Magdalena
MÜLLER, Thomas
SCHMECK, Carsten
BUCHGRABER, Philipp
Author_xml – fullname: DIETZ, Lisa
– fullname: LINDNER, Niels
– fullname: BECKER-PELSTER, Eva Maria
– fullname: MÜLLER, Thomas
– fullname: SCHMECK, Carsten
– fullname: MEIBOM, Daniel
– fullname: BUCHGRABER, Philipp
– fullname: PLATZK, Magdalena
– fullname: HAHN, Michael
– fullname: DELBECK, Martina
BookMark eNrjYmDJy89L5WRQ9vTz8HTyDPEPClbwd1NwdAly9fMPcnV2DQAKgbiOzkY8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwMjY0NDUyNzA0dCYOFUAxwElRA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2023115270A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2023115270A13
IEDL.DBID EVB
IngestDate Fri Aug 16 05:55:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2023115270A13
Notes Application Number: US202017774459
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230413&DB=EPODOC&CC=US&NR=2023115270A1
ParticipantIDs epo_espacenet_US2023115270A1
PublicationCentury 2000
PublicationDate 20230413
PublicationDateYYYYMMDD 2023-04-13
PublicationDate_xml – month: 04
  year: 2023
  text: 20230413
  day: 13
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Bayer Aktiengesellschaft
RelatedCompanies_xml – name: Bayer Aktiengesellschaft
Score 3.4638193
Snippet The present application relates to novel substituted heterocyclic carboxamides, to processes for their preparation, to their use alone or in combinations for...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title INHIBITORS OF ADRENORECEPTOR ADRAC2
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230413&DB=EPODOC&locale=&CC=US&NR=2023115270A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlMKkb8XEfriXIm3a0gprSz9kb6PNUhBkDlfx3_dSOt3T3i4XyMfB5fK7S-4AHnTTWjbCJNpU0EozOBFazSnVkLA45QJhrvR3zGIrLI3XuTkfwMf2L0yXJ_SnS46IGsVR39vuvF7_O7G87m3l5rF-R9bnS1DYntqjY-nhpLrqubafJl7CVMbsMlfjrOujsoQrcRArHeBF-lnqg__myn8p612jEpzCYYrjrdozGIjVCI7ZtvbaCI5mfcgbyV77NucwieIwcqMiyXIlCRTHy_w4yXzmp8iSTYc9XcAk8AsWajjb4m9zizLfXZp-CUOE_eIKlIagqIRuCGE2iKF4XVVkKuqlTNhHlpxfw3jfSDf7u2_hRDZlXITqYxi2X9_iDs1rW993UvkFCgJ6Yw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1MKkb8XGfriXIl3a0urajq6TvZU2TUGQOVzFf99L6XRPe0tykI-DX5LfXe4CcK8ZZllxQ1XGnOSKzlSuFIwQBQsmI4wjzRX2jjAy_YX-sjSWHfjYxsI0eUJ_muSIiCiGeK-b_Xr9b8RymreVm4fiHZs-n73UcuSWHQsLJ9FkZ2K5s9iJqUyptZjLUdLIiPjCVbWRKx3gJftJ4MF9m4i4lPXuoeKdwOEM-1vVp9Dhqz706PbvtT4cha3LG4st-jZnMAoiP5gEaZzMpdiTbCdxozhxqTvDJlG16eM5jDw3pb6Co2V_i8sW892paRfQRdrPL0GqVFQV13TOjQo5FCvyXB3zohQJ-9SSsQEM9_V0tV98Bz0_DafZNIher-FYiISPhGhD6NZf3_wGj9q6uG009AvyUX1W
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INHIBITORS+OF+ADRENORECEPTOR+ADRAC2&rft.inventor=DIETZ%2C+Lisa&rft.inventor=LINDNER%2C+Niels&rft.inventor=BECKER-PELSTER%2C+Eva+Maria&rft.inventor=M%C3%9CLLER%2C+Thomas&rft.inventor=SCHMECK%2C+Carsten&rft.inventor=MEIBOM%2C+Daniel&rft.inventor=BUCHGRABER%2C+Philipp&rft.inventor=PLATZK%2C+Magdalena&rft.inventor=HAHN%2C+Michael&rft.inventor=DELBECK%2C+Martina&rft.date=2023-04-13&rft.externalDBID=A1&rft.externalDocID=US2023115270A1